Katherine High
InvestorScientific Advisory Group Member at Pathway to Cures
Find your path to Katherine
19 people in our graph share verified history with Katherine — schools, employers, funds. One of them is your warm intro.
Teri WilleyunlockedKatherine: together at Pathway to Cures
×11Katherine: together at Pathway to Cures
About
High is a visiting professor at Rockefeller University and pioneer in AAV-mediated gene therapy for hemophilia. She co-founded Spark Therapeutics and served as President of AskBio Therapeutics.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Frequently asked questions
- Who is Katherine High?
- High is a visiting professor at Rockefeller University and pioneer in AAV-mediated gene therapy for hemophilia. She co-founded Spark Therapeutics and served as President of AskBio Therapeutics.
- Where does Katherine High work?
- Katherine High is Scientific Advisory Group Member at Pathway to Cures.